(Q55478862)
Statements
Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate. (English)
1 reference
Han Y
1 reference
Caday CG
1 reference
Umezawa K
1 reference
Nanda A
1 reference
1 January 1997
1 reference
9
1 reference
11-12
1 reference
581-587
1 reference